We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Alignment Healthcare (ALHC) Soars 5.9%: Is Further Upside Left in the Stock?
Read MoreHide Full Article
Alignment Healthcare (ALHC - Free Report) shares ended the last trading session 5.9% higher at $6.08. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.5% loss over the past four weeks.
Alignment Healthcare scored a strong price increase, on investors’ optimism driven by the company’s latest presentation at the Morgan Stanley 21st Annual Global Healthcare Conference in New York City, held on Sep 13, 2023. In addition, the company recently welcomed onboard its chief medical officer — the highly distinguished and co-founder of Alignment Healthcare, Dr. Hyong (Ken) Kim. This might have further boosted investor’s confidence in the stock.
This Medicare Advantage insurer is expected to post quarterly loss of $0.18 per share in its upcoming report, which represents a year-over-year change of +18.2%. Revenues are expected to be $442.77 million, up 22.9% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Alignment Healthcare, the consensus EPS estimate for the quarter has been revised 2.3% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on ALHC going forward to see if this recent jump can turn into more strength down the road.
Alignment Healthcare is part of the Zacks Medical Services industry. Avantor, Inc. (AVTR - Free Report) , another stock in the same industry, closed the last trading session 0.7% higher at $21.87. AVTR has returned 2.6% in the past month.
For Avantor, Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.25. This represents a change of -26.5% from what the company reported a year ago. Avantor, Inc. currently has a Zacks Rank of #4 (Sell).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Alignment Healthcare (ALHC) Soars 5.9%: Is Further Upside Left in the Stock?
Alignment Healthcare (ALHC - Free Report) shares ended the last trading session 5.9% higher at $6.08. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.5% loss over the past four weeks.
Alignment Healthcare scored a strong price increase, on investors’ optimism driven by the company’s latest presentation at the Morgan Stanley 21st Annual Global Healthcare Conference in New York City, held on Sep 13, 2023. In addition, the company recently welcomed onboard its chief medical officer — the highly distinguished and co-founder of Alignment Healthcare, Dr. Hyong (Ken) Kim. This might have further boosted investor’s confidence in the stock.
This Medicare Advantage insurer is expected to post quarterly loss of $0.18 per share in its upcoming report, which represents a year-over-year change of +18.2%. Revenues are expected to be $442.77 million, up 22.9% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Alignment Healthcare, the consensus EPS estimate for the quarter has been revised 2.3% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on ALHC going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Alignment Healthcare is part of the Zacks Medical Services industry. Avantor, Inc. (AVTR - Free Report) , another stock in the same industry, closed the last trading session 0.7% higher at $21.87. AVTR has returned 2.6% in the past month.
For Avantor, Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.25. This represents a change of -26.5% from what the company reported a year ago. Avantor, Inc. currently has a Zacks Rank of #4 (Sell).